Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Xtressé™ Launches the First Stress-Adaptive Hair Therapy System Combining At-Home Daily Ritual with an Exclusive Medical Practice Treatment

Xtressé

News provided by

Xtressé™

Feb 24, 2026, 09:03 ET

Share this article

Share toX

Share this article

Share toX

Following the successful debut of its Hair Growth Gummies, Xtressé™ expands its dermatologist- and-scientist-formulated offerings with the launch of the Xtressé™ Stress-Adaptive Hair Therapy System, including Xvie XO Concentrate and FR Concentrate Serum

ORLANDO, Fla., Feb. 24, 2026 /PRNewswire/ -- Xtressé™, the advanced hair health company founded by dermatologists and scientists, today announced the launch of its first comprehensive stress-adaptive hair therapy system, marking a major milestone following the debut of its Hair Growth Gummies last year. Designed to address hair stress at every stage , including hormonal and age-related changes, the Xtressé™ Hair Therapy System uniquely combines at-home daily ritual with professional-grade, in-office care, delivering a truly end-to-end solution for hair thinning and loss.

Continue Reading
Clinical results following 90 days of daily Xtressé™ Hair Growth Gummies + FR Concentrate Serum (female patient) and 30 days post–in-office microneedle treatment with topical Xvie (male patient). Individual results may vary.
Clinical results following 90 days of daily Xtressé™ Hair Growth Gummies + FR Concentrate Serum (female patient) and 30 days post–in-office microneedle treatment with topical Xvie (male patient). Individual results may vary.

The Xtressé™ Hair Therapy System works as an integrated continuum—nourishing, repairing, and reactivating the hair follicle through both daily and professional care.

Originally launched in 2024, Xtressé™ Hair Growth Gummies quickly established the nutritional foundation of the Xtressé™ system. Today, an estimated 100,000 patients are using Xtressé™ Hair Growth Gummies, and the product is carried by more than 1,000 medical and professional practices nationwide1 - reflecting strong physician adoption and demand for science-backed, dermatologist-formulated hair nutrition.

NOURISH: Hair Growth Gummies are a superfood nutraceutical formulated by dermatologists to nourish follicles from within and combat common hair stressors that disrupt the hair growth cycle. Containing proven, natural bioactive ingredients such as NAD+, Pumpkin Seed Extract, and Saw Palmetto, the gummies are sugar-free, biotin-free and designed for daily use.

In an ongoing, IRB-approved validation study evaluating the efficacy of the Hair Growth Gummies in patients with androgenetic alopecia (AGA), 90% of participants have demonstrated positive results with a measurable reduction in hair loss.2

REPAIR: FR Concentrate Serum is the first and only oligopeptide-blend serum formulated to support follicle repair. The formula is anchored by Xtressé™'s X3-Peptide Complex, combining BPC-157, GHK-Cu (Copper), and Zinc Thymulin to help restore the scalp environment, reduce inflammatory signaling, and support cellular communication at the follicular level—enhanced with caffeine to help energize and stimulate the scalp.

"Every component of this system was engineered based on cellular response data, not trends," said Trillitye Paullin, PhD, Co-Founder of Xtressé™. " FR Concentrate serum is powered by a scientifically optimized oligopeptide ratio and shown to produce a 165% increase in proliferation in Human Hair Outer Root Sheath Cells (HHORSC), critical for follicle structure and support, compared to untreated controls in vitro. We have developed what we believe is the most potent, drug-free regenerative concentrate available to professionals today through a focus on precision, potency, and biological relevance." 

REACTIVATE: Xvie XO Concentrate is a professional-use, multi-signal concentrate designed3 to reactivate the hair follicle, and the first of its kind on the market4. Xvie is all-natural and contains hundreds of trillions of growth factor and peptide molecules, hundreds of billions of exosomes5, natural hyaluronic acid, lipids, and electrolytes, offering a unique bioactive profile designed to support follicle reactivation. Xvie is drug-free, preservative-free, contains no antibiotics, and has no added fragrance.

Xvie is available exclusively for in-office topical administration through qualified medical providers.

"Hair loss is not driven by a single pathway, it's the cumulative impact of stress, inflammation, disrupted signaling, and cellular fatigue over time," said Dr. Matt Leavitt, Co-Founder of Xtressé™. "What we've built with the Xtressé™ system is a coordinated biological strategy that supports the follicle from the inside out and the outside in. By integrating daily nutrition, topical repair, and professional-grade reactivation, we're addressing the full ecosystem that determines long-term follicle performance."

Xtressé™'s Hair Therapy System defines a new category of stress-adaptive hair health, bridging consumer ritual with clinical innovation and is available through qualified medical and professional partners, including Xtressé™ Hair Growth Gummies, FR Concentrate Serum, and Xvie XO Concentrate.

For more information, visit www.xtresse.com

1Xtressé internal sales and distribution data, 2025

2As measured by Socai HairMetrix. Validation study is ongoing. Patients were instructed to take two (2) gummies daily. Individual results may vary. This product is not intended to diagnose, treat, cure, or prevent any disease.

3Internal Assay Study. Publication in Review

4Xtressé internal formulation review and market assessment, 2025.

5Proteomic Analysis. Publication in Review

SOURCE Xtressé™

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia

Xtressé™ Announces FDA IND Acceptance for Xvie, The First & Only Extracellular Vesicle Injectable Therapy for Androgenetic Alopecia

Xtressé™, the advanced hair health company founded by dermatologists and scientists, today announced that the U.S. Food and Drug Administration (FDA) ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Cosmetics and Personal Care

Cosmetics and Personal Care

Medical Pharmaceuticals

Medical Pharmaceuticals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.